According to international market researcher Research and Markets, the global regenerative healthcare market is about $8.5 billion in 2020 and will reach $17.9 billion by 2025, with a compound annual market growth rate of 15.9 percent over the next five years.
In recent years, the increasing incidence of chronic, genetic and cancer diseases has spurred increased investment in innovative therapies and a new high in the regenerative medicine product development pipeline. These are important drivers for the growth of the global regenerative medicine market. On the basis of products, the regenerative medicine market can be divided into tissue engineering products, cell therapies and gene therapies. Cell therapies had the highest growth rate in the regenerative medicine market in 2019.
On the basis of applications, the regenerative medicine market is divided into application areas such as musculoskeletal diseases, wound care, oncology, eye diseases, and dentistry. In 2019, regenerative medicine saw the highest growth in oncology. This can be attributed to the rising prevalence of orthopedic diseases, an increasing aging population, an increase in stem cell research programs, clinical trials, and a growing pipeline of stem cell products for the treatment of musculoskeletal disorders.
Previous
